Pelage Pharmaceuticals, Inc.
🇺🇸United States
Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
Phase 2
Active, not recruiting
- Conditions
- Androgenetic Alopecia
- Interventions
- Drug: PP405 Topical Vehicle Gel
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Pelage Pharmaceuticals, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT06393452
- Locations
- 🇺🇸
Minnesota Clinical Study Center, New Brighton, Minnesota, United States
🇺🇸DermResearch, Austin, Texas, United States
🇺🇸Stride Clinical Research LLC, Sugar Land, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath